GlassScriptPhysician profile
Valerio Bariletti
NPI 1154323780
$3,562.22
in general payments reported to CMS, 2019-2025
19 companies · $381 in 2025
The $381 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2020: $402 · 2021: $461 · 2022: $982 · 2023: $462 · 2024: $670 · 2025: $381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,513.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,512.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $703.20 | 2019-2025 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $604.12 | 2020-2025 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $418.71 | 2019-2025 | Jardiance |
| Lilly USA, LLC | $383.28 | 2020-2025 | Jardiance, Mounjaro, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $347.71 | 2022-2025 | |
| Amgen INC. | $164.12 | 2019-2025 | Repatha, Otezla, Repatha |
| Lexicon Pharmaceuticals, INC. | $147.85 | 2023-2024 | Inpefa |
| Amarin Pharma, INC. | $135.99 | 2020-2023 | |
| Novartis Pharmaceuticals Corporation | $127.54 | 2021-2022 | |
| Pfizer INC. | $113.46 | 2022-2024 | |
| Bardy Diagnostics, INC. | $109.64 | 2020-2022 | |
| Exact Sciences Corporation | $80.63 | 2024-2025 | Cologuard Collection Kit |
| Baxter Healthcare | $72.20 | 2024-2025 | Hillrom - Carnation Ambulatory Monitor |
| Glaxosmithkline, LLC. | $45.04 | 2019-2023 | Shingrix, Arexvy |
| G Medical Diagnostic Services, INC. | $32.21 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $23.32 | 2024 | Xyosted |
| Axsome Therapeutics, INC. | $20.92 | 2022 | |
| Dexcom, INC. | $17.12 | 2023 | Dexcom G6 Transmitter |
| Janssen Pharmaceuticals, INC | $15.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Valerio Bariletti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.